TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Medpace Holdings Inc (MEDP)

Healthcare Diagnostics & Research
577.10 $
-0.2% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Medpace Holdings Inc (MEDP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.1% of the shares are freely tradable; institutional investors hold 88.6%.

Ownership Structure

Institutional ownership
88.6%
Insiders
19.4%
Float
80.1%
Short % of float
9.8%
Shares Outstanding
28Mio.

Largest Shareholders

Institutions

Institutions MEDP
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.85 2,470,440 +2.4 03/31/2026
AQR Capital Management LLC 4.85 1,353,837 +0.3 03/31/2026
Vanguard Portfolio Management, LLC 4.02 1,121,689 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.62 1,011,071 +0.0 03/31/2026
Geode Capital Management, LLC 2.67 745,106 +11.7 03/31/2026
State Street Corp 2.44 682,229 +2.6 03/31/2026
Wasatch Advisors LP 2.28 636,595 -17.7 06/30/2026
Amvescap Plc. 2.07 577,574 +19.7 03/31/2026

Funds

Funds MEDP
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 2.77 771,983 +0.2 07/28/2026
Vanguard Morn Total Stk Mkt Idx Investor 2.60 725,072 +0.4 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
28. Jul 2026 Burwig Susan E Exec. VP, Operations Sell 7,500 600.00 4,500,000
28. Jul 2026 Troendle August J. President & CEO Sell 3,510 600.01 2,106,035
27. Jul 2026 Troendle August J. President & CEO Sell 3,728 600.85 2,239,969

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?